Clinical Trials Browser

Phase 1/2 × Immune Checkpoint Inhibitors × 90 days × Clear all

NCT06502691 2026-05-19

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms

NCT06819735 2026-05-06

DOMISOL

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors